Barclays Maintains Overweight on Incyte, Raises Price Target to $134
Incyte Corporation
Incyte Corporation INCY | 0.00 |
Barclays analyst Etzer Darout maintains Incyte (NASDAQ:
INCY) with a Overweight and raises the price target from $117 to $134.